TrialInternational journal of obesity (2005)2006

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

R H Lustig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.